The legacy success of sildenafil has undeniably shaped the healthcare landscape. However, putting money in companies heavily dependent on biosimilars and the diminishing patent exclusivity surrounding this https://getsocialselling.com/story6900928/sildenafil-and-pharmaceutical-companies-a-risky-opportunity